Evidence map›Paper›PMID 26468278›Full record

ArticleThe Journal of biological chemistry2015

JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1.

Poornima Ramkumar, Clement M Lee, Annie Moradian, Michael J Sweredoski, Sonja Hess, Andrew D Sharrocks, Dale S Haines, E Premkumar Reddy

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Poornima RamkumarFrom the Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Clement M LeeFrom the Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Annie Moradianthe Proteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasadena, California 91125, and.
Michael J Sweredoskithe Proteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasadena, California 91125, and.
Sonja Hessthe Proteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasadena, California 91125, and.
Andrew D Sharrocksthe Faculty of Life Sciences, University of Manchester, Manchester M13 9PL, United Kingdom.
Dale S Hainesthe Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania 19122.
E Premkumar ReddyFrom the Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, ep.reddy@mssm.edu.
California Institute of Technology · USIcahn School of Medicine at Mount Sinai · USTemple University · USUniversity of Manchester · GB

Funding

Targeting Mitotic Kinases Inhibitors for Cancer TherapyR01CA158209 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI REDDY, E PREMKUMAR · 2012 to 2016
$1.7M
NCI NIH HHS R01 CA158209NCI NIH HHS R01CA158209
6 · The paper itself

Abstract

JLP (JNK-associated leucine zipper protein) is a scaffolding protein that interacts with various signaling proteins associated with coordinated regulation of cellular process such as endocytosis, motility, neurite outgrowth, cell proliferation, and apoptosis. Here we identified PLK1 (Polo-like kinase 1) as a novel interaction partner of JLP through mass spectrometric approaches. Our results indicate that JLP is phospho-primed by PLK1 on Thr-351, which is recognized by the Polo box domain of PLK1 leading to phosphorylation of JLP at additional sites. Stable isotope labeling by amino acids in cell culture and quantitative LC-MS/MS analysis was performed to identify PLK1-dependent JLP-interacting proteins. Treatment of cells with the PLK1 kinase inhibitor BI2536 suppressed binding of the Forkhead box protein K1 (FOXK1) transcriptional repressor to JLP. JLP was found to interact with PLK1 and FOXK1 during mitosis. Moreover, knockdown of PLK1 affected the interaction between JLP and FOXK1. FOXK1 is a known transcriptional repressor of the CDK inhibitor p21/WAF1, and knockdown of JLP resulted in increased FOXK1 protein levels and a reduction of p21 transcript levels. Our results suggest a novel mechanism by which FOXK1 protein levels and activity are regulated by associating with JLP and PLK1.

Indexed as

Gene Expression RegulationAdaptor Proteins, Signal TransducingAnimalsAntimitotic AgentsCell Cycle ProteinsCell Line, TumorCell ProliferationForkhead Transcription FactorsHEK293 CellsHeLa CellsHumansMass SpectrometryMiceMitosisPhosphorylationPolo-Like Kinase 1Adaptor Proteins, Signal TransducingAntimitotic AgentsBI 2536Cell Cycle ProteinsForkhead Transcription FactorsFOXK1 protein, humanPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsPteridinesSPAG9 protein, humanSpag9 protein, mouseFOXK1JLPmitosisphosphorylationPLK1protein-protein interactionscaffold proteinserine/threonine protein kinasetranscription factor

Identifiers

PMID26468278
PMCPMC4705960
OpenAlexW2183527266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.